Your session is about to expire
← Back to Search
Patient Activation Program for Low Anterior Resection Syndrome
Study Summary
This trial will test whether a LARS Patient-Centered Program is more effective than usual care in improving PROMs after restorative proctectomy.
- Low Anterior Resection Syndrome
- Colorectal Cancer
- Patient Activation
- Surgery
- Low Anterior Resection
- Anterior Resection Syndrome
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently receiving chemotherapy or radiation treatment.You had a major surgery to remove part of your colon and rectum.
- Group 1: Standard Care Arm
- Group 2: Patient Activation Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the geographical locations that offer access to this research?
"This clinical trial has 6 open locations in Canada, including McGill University Health Centre (Montréal), CHU de Quebec (Québec) and Jewish General Hospital (Montreal). An additional 3 sites are located elsewhere."
What is the number of individuals included in this clinical trial?
"Affirmative, according to clinicaltrials.gov the trial is actively recruiting patients and has been since September 1st 2019. The study requires 128 participants from 6 medical sites with its most recent update being on August 17th 2022."
Does this trial accommodate individuals aged seventy-five and above?
"According to the study's entry requirements, prospective participants must be 18 years or older and not exceed 99."
Am I eligible to join this research endeavor?
"Candidates wishing to participate in this medical trial must demonstrate symptoms of the relevant syndrome, as well as fall within a specified age range (18 - 99). This study is aiming to recruit around 128 people."
Does this research require any further participants?
"Confirmed. Clinicaltrials.gov notes that this medical trial, which was initially posted on September 1st 2019, is actively accepting patients for study enrolment. The protocol calls for 128 participants to be recruited from 6 separate sites of care."
Share this study with friends
Copy Link
Messenger